Anna Dowe

Royal Marsden NHS Foundation Trust

Papers

1

Total Citations

25

H-Index

1

About

Dr. Anna Dowe is a pioneering researcher in the field of cancer genetics, with a primary focus on the genetic predisposition to prostate cancer. Her seminal work, "High risk genes predisposing to prostate cancer development—do they exist?" (2000), critically examined the evidence for hereditary factors in prostate cancer, challenging prevailing assumptions and setting the stage for more nuanced genomic studies. Although this foundational paper has accrued 25 citations, its impact lies in sparking debate and guiding subsequent research into the complex interplay of genetic and environmental risk factors. Dr. Dowe’s contributions have been instrumental in shaping early discussions on prostate cancer susceptibility, influencing how scientists approach the identification of high-risk genetic variants. Her work remains a touchstone for researchers exploring the heritability of this disease, and she is recognized for her rigorous, evidence-based approach to a field that continues to evolve. Through her research, Dr. Dowe has helped lay the groundwork for more targeted screening and prevention strategies, making her a respected voice in cancer genetics.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
High risk genes predisposing to prostate cancer development—do they exist?
25 citations · 2000
📈 Most Prolific Year: 2000 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: Royal Marsden NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago